Actively Recruiting
Electroacupuncture on Treating Cancer-related Depression
Led by Shanghai Municipal Hospital of Traditional Chinese Medicine · Updated on 2025-12-23
86
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cancer-related depression (CRD) is a common psychological condition among cancer patients during diagnosis, treatment, and recovery, and is associated with reduced quality of life, impaired immune function, and poorer clinical outcomes. As cancer incidence and mortality continue to rise in China, the psychological burden on patients is receiving increasing attention. Electroacupuncture (EA) has shown potential in treating various types of depression and related somatic symptoms, but evidence regarding its efficacy, safety, and long-term effects in CRD remains limited. This randomized controlled trial aims to evaluate the short- and long-term efficacy and safety of EA for CRD, with the goal of providing evidence to support effective and optimized treatment strategies.
CONDITIONS
Official Title
Electroacupuncture on Treating Cancer-related Depression
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Presence of depression caused by cancer or cancer treatments, meeting DSM-V criteria for depressive disorder
- Age between 18 and 75 years, any gender
- Baseline Hamilton Depression Rating Scale-17 score greater than 17
- Eastern Cooperative Oncology Group performance status score of 2 or less
- No previous acupuncture treatment
- Ability to understand study procedures and provide written informed consent
You will not qualify if you...
- Planned surgery, chemotherapy, radiotherapy, immunotherapy, or other active cancer treatments during the study
- History of major depressive episodes before cancer diagnosis
- Cancer-related pain with a Pain Rating Index score of 4 or higher
- Life expectancy of 12 months or less
- Severe ulcers, abscesses, or active skin infections near acupuncture sites
- Serious dysfunction of major organs or other severe systemic illnesses
- Pregnant or breastfeeding women
- Participation in another clinical trial within the past 30 days
- Presence of a cardiac pacemaker or implanted electronic medical devices
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Municipal Hospital of Traditional Chinese Medicine
Shanghai, China
Actively Recruiting
Research Team
X
Xuan Yin, Doctor
CONTACT
T
Tao Guo, Master
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here